InvestorsHub Logo

BioBull1

03/10/17 10:44 AM

#5725 RE: DDobserver #5724

'Tweaking' as it was put can not occur to the scaffold without starting over. Additionally, any tweaking to the criteria set forth and agreed to by the FDA would require the Inspire trial protocol to be update which it has not.

https://clinicaltrials.gov/ct2/show/NCT02138110?term=%22invivo+therapeutics%22&rank=1